Major depressive disorder
RH Belmaker, G Agam - New England Journal of Medicine, 2008 - Mass Medical Soc
This review of major depressive disorder is a comprehensive account of the genetic,
biochemical, and neurophysiological changes that have been implicated in the disorder. No …
biochemical, and neurophysiological changes that have been implicated in the disorder. No …
The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice
JF Cryan, C Mombereau, A Vassout - Neuroscience & Biobehavioral …, 2005 - Elsevier
Since its introduction almost 20 years ago, the tail suspension test has become one of the
most widely used models for assessing antidepressant-like activity in mice. The test is based …
most widely used models for assessing antidepressant-like activity in mice. The test is based …
New approaches to antidepressant drug discovery: beyond monoamines
O Berton, EJ Nestler - Nature Reviews Neuroscience, 2006 - nature.com
All available antidepressant medications are based on serendipitous discoveries of the
clinical efficacy of two classes of antidepressants more than 50 years ago. These tricyclic …
clinical efficacy of two classes of antidepressants more than 50 years ago. These tricyclic …
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
A Taly, PJ Corringer, D Guedin, P Lestage… - Nature reviews Drug …, 2009 - nature.com
Nicotinic receptors—a family of ligand-gated ion channels that mediate the effects of the
neurotransmitter acetylcholine—are among the most well understood allosteric membrane …
neurotransmitter acetylcholine—are among the most well understood allosteric membrane …
Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application
MJ Millan - Pharmacology & therapeutics, 2006 - Elsevier
Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a
high social cost. Depressed patients generally display co-morbid symptoms, and depression …
high social cost. Depressed patients generally display co-morbid symptoms, and depression …
The medical management of depression
JJ Mann - New England Journal of Medicine, 2005 - Mass Medical Soc
The Medical Management of Depression | New England Journal of Medicine Skip to main content
The New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
The New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
Smoking, nicotine and neuropsychiatric disorders
P Dome, J Lazary, MP Kalapos, Z Rihmer - Neuroscience & Biobehavioral …, 2010 - Elsevier
Tobacco smoking is an extremely addictive and harmful form of nicotine (NIC) consumption,
but unfortunately also the most prevalent. Although disproportionately high frequencies of …
but unfortunately also the most prevalent. Although disproportionately high frequencies of …
Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents
Y Shirayama, S Chaki - Current neuropharmacology, 2006 - ingentaconnect.com
There is accumulating evidence that the nucleus accumbens (NAc) plays an important role
in the pathophysiology of depression. Given that clinical depression is marked by anhedonia …
in the pathophysiology of depression. Given that clinical depression is marked by anhedonia …
Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature
Many patients with depression fail to derive sufficient benefit from available treatment
options, with up to a third never reaching remission despite multiple trials of appropriate …
options, with up to a third never reaching remission despite multiple trials of appropriate …
[HTML][HTML] Pathophysiology of nAChRs: limbic circuits and related disorders
Human epidemiological studies have identified links between nicotine intake and stress
disorders, including anxiety, depression and PTSD. Here we review the clinical evidence for …
disorders, including anxiety, depression and PTSD. Here we review the clinical evidence for …